A huge congratulations to Eric Thompson, MD, who was recently awarded an R01 grant from the National Institutes of Health (NIH)!
He will use this to support his project, which focuses on cancer treatment research and aims to conduct a multi-institutional Phase I/II trial. This trial uses a novel brain tumor vaccine combined with an agent that increases immune responses to treat children and young adults with malignant glioma, diffuse midline glioma, medulloblastoma, and ependymoma. His efforts are crucial to advancing medical research, and we commend his hard work and dedication.
To learn more about him and his research click here
